Need professional-grade analysis? Visit stockanalysis.com
N/A
N/A
N/A
N/A
Price Chart
Risk-Adjusted Performance
Also Listed On
Virbac SA (0NM7) Price Performance
Virbac SA (0NM7) trades on London Stock Exchange in GBP. The stock currently trades at GBP385.50, up 7.23% from the previous close.
Over the past year, 0NM7 has traded between a low of GBP330.50 and a high of GBP385.50. The stock has gained 9.7% over this period. It is currently 16.6% above its 52-week low.
About Virbac SA
Virbac SA is a French multinational pharmaceutical company that specializes in the development, production, and distribution of veterinary medicines and vaccines. The company's primary focus is on companion animals and livestock, offering a wide range of products to improve the health and well-being of animals worldwide. Virbac operates in more than 100 countries and is recognized as a leading player in the global animal health industry.
Company Info
- Sector
- N/A
- Industry
- N/A
- Exchange
- London Stock Exchange
- Currency
- GBP
- Country
- United Kingdom
Financial Metrics
- Revenue (TTM)
- $1.46B
- EBITDA
- $290.25M
- Profit Margin
- 10.30%
- EPS (TTM)
- N/A
- Book Value
- 127.13
Technical Indicators
- 52 Week High
- £385.50
- 52 Week Low
- £330.50
- 50 Day MA
- N/A
- 200 Day MA
- N/A
- Beta
- 0.81
Valuation
- Trailing P/E
- N/A
- Forward P/E
- N/A
- Price/Sales
- N/A
- Price/Book
- 2.76
- Enterprise Value
- N/A